Psoriasis: ⁣Beyond an Immune Disorder

For decades, psoriasis has been primarily understood as ‌an immune-mediated disease. However,⁢ new research from ​the Medical University of Vienna ⁢challenges this ⁢conventional wisdom, demonstrating a crucial link⁣ between the condition ⁢and disruptions in how skin cells process lipids (fats). Professor Irvine Wagner,leading the research team,stated on December 12,2023,”Our results confirm that psoriasis is not⁣ only an immune disorder,but is also closely linked to a defect in lipid metabolism within skin cells.” Al nahdan News reported on the ‌discovery.

Psoriasis⁤ affects an estimated 7.5 million adults in the United States, and approximately 80%⁤ of⁤ those affected‌ experience mild to moderate symptoms, while⁢ 20% have moderate to severe disease. The National Psoriasis Foundation provides detailed information on disease‍ severity.

The Role of FABP5: A Potential Biomarker

The research⁢ identified FABP5 (Fatty Acid Binding protein 5) as a key player in this lipid metabolism dysfunction. Kazuhiko Matsuoka, a researcher involved in​ the study, highlighted the potential of FABP5, stating on December 12, ‌2023, ⁢”FABP5 may ⁢in the future become a biomarker that helps develop targeted therapies, especially for patients who do not respond well to conventional immunotherapies.”